ATNM
Price
$1.48
Change
+$0.02 (+1.37%)
Updated
Oct 17, 11:41 AM (EDT)
Capitalization
45.55M
38 days until earnings call
Intraday Buy/Sell Signals
RXRX
Price
$5.96
Change
-$0.40 (-6.29%)
Updated
Oct 17, 01:40 PM (EDT)
Capitalization
2.78B
19 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ATNM vs RXRX

Header iconATNM vs RXRX Comparison
Open Charts ATNM vs RXRXBanner chart's image
Actinium Pharmaceuticals
Price$1.48
Change+$0.02 (+1.37%)
Volume$300
Capitalization45.55M
Recursion Pharmaceuticals
Price$5.96
Change-$0.40 (-6.29%)
Volume$58.91K
Capitalization2.78B
ATNM vs RXRX Comparison Chart in %
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. RXRX commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (ATNM: $1.46 vs. RXRX: $6.36)
Brand notoriety: ATNM and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 151% vs. RXRX: 612%
Market capitalization -- ATNM: $45.55M vs. RXRX: $2.78B
ATNM [@Biotechnology] is valued at $45.55M. RXRX’s [@Biotechnology] market capitalization is $2.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $104.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 6 bullish TA indicator(s).

  • ATNM’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -2.67% price change this week, while RXRX (@Biotechnology) price change was +7.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.61%. For the same industry, the average monthly price growth was +16.03%, and the average quarterly price growth was +79.34%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.78B) has a higher market cap than ATNM($45.5M). ATNM YTD gains are higher at: 15.873 vs. RXRX (-5.917). ATNM has higher annual earnings (EBITDA): -43.43M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. ATNM (59.9M). ATNM has less debt than RXRX: ATNM (1.29M) vs RXRX (88.1M). RXRX has higher revenues than ATNM: RXRX (64.5M) vs ATNM (0).
ATNMRXRXATNM / RXRX
Capitalization45.5M2.78B2%
EBITDA-43.43M-583.64M7%
Gain YTD15.873-5.917-268%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash59.9M525M11%
Total Debt1.29M88.1M1%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMRXRX
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
72%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLW19.190.20
+1.05%
Clearwater Paper Corp
CSCO69.09-0.43
-0.62%
Cisco Systems
UGI32.15-0.41
-1.26%
UGI Corp
EVLV8.08-0.18
-2.18%
Evolv Technologies Holdings
SDST5.26-0.84
-13.77%
Stardust Power Inc.

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with CRBU. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-5.81%
CRBU - ATNM
44%
Loosely correlated
-5.99%
IPSC - ATNM
43%
Loosely correlated
-2.25%
RXRX - ATNM
42%
Loosely correlated
-6.33%
CRSP - ATNM
40%
Loosely correlated
-4.72%
ACHV - ATNM
39%
Loosely correlated
-3.14%
More